Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 51 Enz. Inhib. hit(s) with all data for entry = 50040113
TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389319(CHEMBL2063924)
Affinity DataIC50:  2nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50380257(CHEMBL2017253)
Affinity DataIC50:  8nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMedPDB3D3D Structure (crystal)

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50380246(CHEMBL2017214)
Affinity DataIC50:  12nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMedPDB3D3D Structure (crystal)

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389323(CHEMBL2063925)
Affinity DataIC50:  15nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389321(CHEMBL2063927)
Affinity DataIC50:  28nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389322(CHEMBL2063929)
Affinity DataIC50:  30nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389311(CHEMBL2063916)
Affinity DataIC50:  40nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389318(CHEMBL2063923)
Affinity DataIC50:  43nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50:  48nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389307(CHEMBL2063928)
Affinity DataIC50:  50nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389309(CHEMBL2063914)
Affinity DataIC50:  58nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389312(CHEMBL2063917)
Affinity DataIC50:  66nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389308(CHEMBL2063913)
Affinity DataIC50:  70nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389310(CHEMBL2063915)
Affinity DataIC50:  110nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389319(CHEMBL2063924)
Affinity DataIC50:  150nMAssay Description:Inhibition of KHKC in human HepG2 cells assessed as level of fructose-1-phosphateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389314(CHEMBL2063919)
Affinity DataIC50:  300nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389313(CHEMBL2063918)
Affinity DataIC50:  440nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50380246(CHEMBL2017214)
Affinity DataIC50: <500nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMedPDB3D3D Structure (crystal)

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389316(CHEMBL2063921)
Affinity DataIC50:  800nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389315(CHEMBL2063920)
Affinity DataIC50:  4.60E+3nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetKetohexokinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389317(CHEMBL2063922)
Affinity DataIC50:  6.00E+3nMAssay Description:Inhibition of recombinant human hepatic KHKCMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetCasein kinase I isoform delta(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of CSNK1D by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetInsulin receptor(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of INSR by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetGlycogen synthase kinase-3 beta(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of GSK3B by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetSerine/threonine-protein kinase Nek2(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of NEK2 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetSerine/threonine-protein kinase Chk2(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of CHEK2 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetAurora kinase A(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of AURKA by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetSerine/threonine-protein kinase 26(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of MST4 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetProtein kinase C theta type(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of PRKCQ by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetEpidermal growth factor receptor(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of EGFR by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetEphrin type-B receptor 1(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of EPHB1 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetInterleukin-1 receptor-associated kinase 4(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of IRAK4 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetSerine/threonine-protein kinase Chk1(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of CHEK1 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetSerine/threonine-protein kinase pim-2(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of PIM2 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetcAMP-dependent protein kinase catalytic subunit alpha(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of PRKACA by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetCyclin-dependent kinase/G2/mitotic-specific cyclin- 1(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of CDK1/cyclin B by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetDeath-associated protein kinase 3(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of DAPK3 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

Target5'-AMP-activated protein kinase catalytic subunit alpha-1/subunit beta-1/subunit gamma-1(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of AMPK A1/B1/G1 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetRho-associated protein kinase 1(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of ROCK1 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetActivin receptor type-1B(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of ALK4 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetCalcium/calmodulin-dependent protein kinase type 1D(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of CAMK1D by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetSerine/threonine-protein kinase PAK 3(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of PAK3 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetSerine/threonine-protein kinase PLK3(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of PLK3 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetMitogen-activated protein kinase 13(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of MAPK13 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetRAC-alpha serine/threonine-protein kinase(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of AKT1 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetRibosomal protein S6 kinase alpha-3(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of RPS6KA3 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetTyrosine-protein kinase JAK2(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of JAK2 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetTyrosine-protein kinase ABL1(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of ABL1 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetHigh affinity nerve growth factor receptor(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of NTRK1 by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Janssen Pharmaceutical Companies of Johnson & Johnson

Curated by ChEMBL
LigandPNGBDBM50389320(CHEMBL2063926)
Affinity DataIC50: <1.00E+4nMAssay Description:Inhibition of SRC by FRET assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

Displayed 1 to 50 (of 51 total ) | Next | Last >>
Jump to: